Scaling cGMP mRNA Drug Substance Manufacturing: Process, Quality, and CDMO Selection
Learn how an integrated mRNA drug substance CDMO streamlines IVT, LNP formulation, and tech transfer. Explore BioCina’s Adelaide suite capabilities.…
BioCina Resources Hub
Curated insights, technical guides, and industry updates from a global CDMO leader.
Selecting a cGMP Microbial Fermentation CDMO: Key Capabilities & Considerations
Microbial fermentation remains one of the most established platforms for microbial drug substance manufacturing……
What Is Cytotoxic Drug Manufacturing?
Cytotoxic drug manufacturing is a specialized area of pharmaceutical production focused on the safe handling, formulation, and fill-finish of compounds…
Why Blow Fill Seal Technology Is Growing in Pharmaceutical Manufacturing
Blow fill seal technology is one of the fastest-growing segments in sterile pharmaceutical manufacturing. A single continuous automated process forms,…
What Is an Isolator Filling Workcell?
An isolator filling workcell is a robotic, closed-system aseptic filling platform designed to eliminate human presence from the critical fill…
Agility in Biomanufacturing: The Key to Overcoming Uncertainty
In today’s biopharma landscape, resilience isn’t enough — CDMOs must also be agile. Agility enables clients to adjust quickly to…
What’s next for mRNA after COVID-19?
The pandemic proved that mRNA-based vaccines could be developed, manufactured, and distributed globally in record time. But the real promise…
Expanding LNP Applications Beyond mRNA Vaccines
Lipid nanoparticles (LNPs) have transformed how we deliver mRNA. But their role in modern medicine is just beginning. In this…
Integrated mRNA-LNP Manufacturing Services
Thousands of mRNA-based vaccines and therapies are in development, but progressing from discovery to clinical trials is far from simple.…
Looking for Something Specific?
If you can't find what you need, our team can provide tailored resources and program-specific information to help move your program forward.